loader

corvus pharmaceuticals

LATEST ARTICLES

Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas

pharmaceutical investing

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006

pharmaceutical investing

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

pharmaceutical investing

Corvus Presents Provisional Data On CPI-444

Vernalis Announces Results Announcement for the 12 Months Ended 30 June 2016

Corvus Pharmaceuticals Announces Preclinical and Preliminary Clinical Biomarker Data

Corvus Pharmaceuticals to Present Data on Lead Oral Checkpoint Inhibitor CPI-444 at Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Biotech Investing

Two Gene-focused Biotech Companies File for IPOs

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES